Marshall Wace North America L.P. - INTEC PHARMA LTD JERUSALEM ownership

INTEC PHARMA LTD JERUSALEM's ticker is and the CUSIP is M53644106. A total of 41 filers reported holding INTEC PHARMA LTD JERUSALEM in Q1 2019. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.

Quarter-by-quarter ownership
Marshall Wace North America L.P. ownership history of INTEC PHARMA LTD JERUSALEM
ValueSharesWeighting
Q1 2019$234,00031,9740.00%
Other shareholders

There were no reported owners of INTEC PHARMA LTD JERUSALEM in Q1 2019.

NameSharesValueWeighting ↓
View complete list of INTEC PHARMA LTD JERUSALEM shareholders